110 related articles for article (PubMed ID: 24548303)
21. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
Bianchi M; Meng C; Ivashkiv LB
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9573-8. PubMed ID: 10920190
[TBL] [Abstract][Full Text] [Related]
22. Impaired STAT phosphorylation in T cells from melanoma patients in response to IL-2: association with clinical stage.
Mortarini R; Vegetti C; Molla A; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Anichini A
Clin Cancer Res; 2009 Jun; 15(12):4085-94. PubMed ID: 19509154
[TBL] [Abstract][Full Text] [Related]
23. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line.
Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Nakamura M; Van Snick J; Sugamura K
Eur J Immunol; 1996 Jun; 26(6):1322-7. PubMed ID: 8647212
[TBL] [Abstract][Full Text] [Related]
24. Vanadium pentoxide prevents NK-92MI cell proliferation and IFNγ secretion through sustained JAK3 phosphorylation.
Gallardo-Vera F; Diaz D; Tapia-Rodriguez M; Fortoul van der Goes T; Masso F; Rendon-Huerta E; Montaño LF
J Immunotoxicol; 2016; 13(1):27-37. PubMed ID: 25565016
[TBL] [Abstract][Full Text] [Related]
25. Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.
Lopez TV; Lappin TR; Maxwell P; Shi Z; Lopez-Marure R; Aguilar C; Rocha-Zavaleta L
Int J Cancer; 2011 Dec; 129(11):2566-76. PubMed ID: 21442620
[TBL] [Abstract][Full Text] [Related]
26. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
[TBL] [Abstract][Full Text] [Related]
27. Uncoupling JAK3 activation induces apoptosis in human lymphoid cancer cells via regulating critical survival pathways.
Nagy ZS; Ross JA; Rodriguez G; Bader J; Dimmock J; Kirken RA
FEBS Lett; 2010 Apr; 584(8):1515-20. PubMed ID: 20211620
[TBL] [Abstract][Full Text] [Related]
28. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome.
Bullenkamp J; Mengoni V; Kaur S; Chhetri I; Dimou P; Astroulakis ZMJ; Kaski JC; Dumitriu IE
Cardiovasc Res; 2021 Jul; 117(8):1935-1948. PubMed ID: 32647892
[TBL] [Abstract][Full Text] [Related]
30. Membrane microdomains and cytoskeleton organization shape and regulate the IL-7 receptor signalosome in human CD4 T-cells.
Tamarit B; Bugault F; Pillet AH; Lavergne V; Bochet P; Garin N; Schwarz U; Thèze J; Rose T
J Biol Chem; 2013 Mar; 288(12):8691-8701. PubMed ID: 23329834
[TBL] [Abstract][Full Text] [Related]
31. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Kolenko V; Wang Q; Riedy MC; O'Shea J; Ritz J; Cathcart MK; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
J Immunol; 1997 Sep; 159(6):3057-67. PubMed ID: 9300731
[TBL] [Abstract][Full Text] [Related]
32. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
[TBL] [Abstract][Full Text] [Related]
33. STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.
Nagy ZS; LeBaron MJ; Ross JA; Mitra A; Rui H; Kirken RA
Mol Cancer; 2009 Aug; 8():67. PubMed ID: 19709433
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity.
Cheng H; Ross JA; Frost JA; Kirken RA
Mol Cell Biol; 2008 Apr; 28(7):2271-82. PubMed ID: 18250158
[TBL] [Abstract][Full Text] [Related]
35. Receptor expression is essential for proliferation induced by dimerized Jak kinases.
Fujii H
Biochem Biophys Res Commun; 2008 Jun; 370(4):557-60. PubMed ID: 18381062
[TBL] [Abstract][Full Text] [Related]
36. JAK kinases overexpression promotes in vitro cell transformation.
Knoops L; Hornakova T; Royer Y; Constantinescu SN; Renauld JC
Oncogene; 2008 Mar; 27(11):1511-9. PubMed ID: 17873904
[TBL] [Abstract][Full Text] [Related]
37. Regulation of IL-2 signaling.
Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Sugamura K
Leukemia; 1997 Apr; 11 Suppl 3():416-7. PubMed ID: 9209410
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.
Marzec M; Halasa K; Kasprzycka M; Wysocka M; Liu X; Tobias JW; Baldwin D; Zhang Q; Odum N; Rook AH; Wasik MA
Cancer Res; 2008 Feb; 68(4):1083-91. PubMed ID: 18281483
[TBL] [Abstract][Full Text] [Related]
39. Evidence that cervical cancer cells secrete IL-2, which becomes an autocrine growth factor.
Rangel-Corona R; Corona-Ortega T; Soto-Cruz I; López-Labra A; Pablo-Arcos T; Torres-Guarneros CF; Weiss-Steider B
Cytokine; 2010 Jun; 50(3):273-7. PubMed ID: 20227890
[TBL] [Abstract][Full Text] [Related]
40. Inflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells.
Workman AM; Jacobs AK; Vogel AJ; Condon S; Brown DM
PLoS One; 2014; 9(2):e89010. PubMed ID: 24586481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
